This Cancer Detection Stock May Have Just Turned the Corner

A new PET imaging agent is showing early signs of outperforming standard MRI in detecting brain metastases, and regulators are already paying attention.

With Fast Track designation secured and pivotal trials on the horizon, this platform could soon be positioned at the center of a $500M+ market.

Many investors are seeing solid gains in today’s market, but solid gains often hide opportunities with far greater potential.

A new analysis highlights the 5 Stocks Set to Double, selected from thousands of companies showing early signs of powerful growth.

These picks feature strong fundamentals and technical indicators that often appear before meaningful upside.

Past editions of this research uncovered gains of +175%, +498%, and +673%.

Download the 5 Stocks Set to Double. Free Today.

U.S. stocks slipped today as investors continued rotating out of big tech amid valuation concerns and rising Treasury yields.

Nvidia outperformed on an analyst upgrade, but broader tech weakness weighed on indexes.

Markets are also in wait-and-see mode ahead of key economic data and signals on future Fed leadership.

Phillips 66 (NYSE: PSX) approved a $2.4 billion capital plan for 2026, and the intent behind it is unmistakable.

Growth capital is being pushed toward assets that generate predictable cash instead of volatile volume.

That distinction matters because you get clarity in how capital is being deployed, not just how much.

The focus is returns first, resilience second, and expansion only where margins justify it.

Midstream Takes the Lead

Midstream infrastructure is the backbone of this plan, with new gas processing, pipelines, and fractionation capacity centered in Texas and the Permian Basin.

These projects are built to capture value from rising natural gas liquids production and export demand.

What stands out is how efficiently these assets scale, and you see flexibility baked into the design, not dependent on perfect market conditions.

That gives Phillips 66 durable earnings even when cycles shift.

Refining, But With Discipline

Refining investments are aimed at yield improvement, crude flexibility, and product optimization rather than brute-force capacity growth.

This approach pairs directly with Phillips 66, taking full control of WRB Refining.

You are seeing those moves tighten operational control into a system where feedstocks, processing, and monetization line up cleanly.

The result is a cash-focused platform built to perform well beyond 2026.

BlackRock (NYSE: BLK) has officially taken over management of $80 billion tied to Citigroup’s private banking clients, turning a long-standing partnership into full operational control.

This is one of the largest private-wealth portfolio migrations ever executed at a global scale.

Once the transition completes, you are no longer looking at BlackRock as a helper, but as the engine deciding allocation, risk, and strategy.

Citi steps back from direct management, while BlackRock steps squarely into the driver’s seat.

No Shockwaves, Just More Power

The shift was designed for continuity, not upheaval, with Citi investment professionals moving over to preserve client strategies and relationships.

That structure keeps portfolios steady while expanding what those clients can access.

Under one platform, you suddenly have legacy wealth strategies plugged into BlackRock’s full machine, from public markets to alternatives and private credit.

It is a scale added without resetting trust.

When Wealth Starts Running on BlackRock

Strategically, this move pushes BlackRock deeper into ultra-high-net-worth and private banking channels across multiple regions.

It also expands its separately managed account business beyond the U.S. in a meaningful way.

At this level, you are watching BlackRock become infrastructure, not just an asset manager.

The firm is positioning itself as the default system through which global wealth is invested, monitored, and grown.

A powerful shift in America’s AI landscape is underway, and a new group of companies is positioned to benefit.

A free report reveals 9 AI-driven operations showing strong revenue trends and real domestic expansion.

These picks come from sectors seeing faster adoption, lighter regulatory pressure and growing infrastructure demand.

Investors watching early indicators may find the timing advantageous.

Get the Free Report

Google (NASDAQ: GOOGL) has crossed a structural threshold where artificial intelligence is no longer experimental or optional.

AI now organizes how Search, YouTube, Cloud, and productivity tools are built, shipped, and scaled.

Products like Gemini and AI Overviews are no longer previews running on the edges. They are live systems influencing billions of daily interactions across the internet.

Results Start Showing Up on the Income Statement

The shift is already translating into performance, with Google posting a record quarter, with revenue above $100 billion.

Instead of breaking its core model, AI is reinforcing it by improving engagement, efficiency, and monetization.

While rivals scramble for outside compute, Google is operating from a position you rarely see: infrastructure that has been quietly in place for more than a decade.

Custom chips and global data centers are now paying off.

One Platform, Intelligence Everywhere

Google is not selling AI as a single product or subscription.

Intelligence is being layered across search queries, cloud workloads, video discovery, and autonomous systems, shaping decisions long before you realize AI is involved.

That breadth matters because it resets competitive dynamics across tech.

Google is no longer reacting to the AI cycle; it is shaping how scale, deployment, and adoption actually work.

👉 Click here to get our closing report to your cell for free!

Radiopharm Theranostics Limited [RADX] $10.63 (+149.53%)

Radiopharm surged after interim Phase 2b data showed 92% concordance with MRI imaging, validating strong and selective tumor uptake in brain metastases.

Artiva Biotherapeutics Inc [ARTV] $6.30 (+90.91%)

Artiva climbed as bullish analyst commentary highlighted accelerating clinical progress and potential triple‑digit upside for its NK cell therapy in autoimmune diseases.

Kyverna Therapeutics Inc [KYTX] $10.82 (+23.23%)

Kyverna soared after reporting transformative Phase 2 results showing its CAR‑T therapy reversed disability in stiff person syndrome with a favorable safety profile.

ReNew Energy Global Plc [RNW] $5.50 (-27.15%)

ReNew tumbled 24% after Masdar withdrew from a buyout consortium, ending hopes for a near-term premium exit deal.

Velo3D Inc [VELO] $9.71 (-18.54%)

Velo3D slipped as profit-taking set in following a steep rally fueled by recent SpaceX and Anduril partnership news.

Hut 8 Corp [HUT] $35.44 (-14.21%)

Hut 8 dropped as continued Bitcoin weakness and ABTC underperformance reignited concerns about its leveraged crypto exposure.

 I'd like to give you a free copy of our brand-new report: 7 Best Stocks for the Next 30 Days.

Our objective, mathematical stock prediction system has consistently outperformed the market — delivering strong returns over decades.

This just-released Special Report reveals the 7 most explosive stocks from our top-ranked selections.

Fewer than 5% of stocks qualify to be one of our “7 Best.” These could be the most exciting short-term trades in your portfolio.

Don’t wait — see these picks before your next trade. Download it now, absolutely free.

[Click Here for the Free Report]

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.